| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 5 | OFFSIDES US FAERS | |
| 2 | Tamoxifen | FAERS: 3 | US FAERS | |
| 3 | Aripiprazole | FAERS: 2 | US FAERS | |
| 4 | Everolimus | FAERS: 2 | US FAERS | |
| 5 | etonogestrel | FAERS: 2 | US FAERS | |
| 6 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 7 | Mitotane | FAERS: 1 | US FAERS | |
| 8 | Tamoxifen | FAERS: 1 | OFFSIDES US FAERS | |
| 9 | Amantadine | OFFSIDES | ||
| 10 | Baclofen | OFFSIDES | ||
| 11 | Clomiphene | OFFSIDES | ||
| 12 | Pramipexole | OFFSIDES | ||
| 13 | carbidopa, levodopa drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.